tmmonline.nz  |   landlords.co.nz        About Good Returns  |  Advertise  |  Contact Us  |  Terms & Conditions  |  RSS Feeds

NZ's Financial Adviser News Centre

GR Logo
Last Article Uploaded: Thursday, February 6th, 9:15AM

Insurance

rss
Latest Headlines

Unimed gets ratings diagnosis

Christchurch-based Unimed, which operates mainly in the group health insurance business has been delivered its latest ratings update from AM Best.

Wednesday, July 4th 2012, 1:34PM

AM Best has affirmed the financial strength rating of A- (Excellent) and issuer credit rating of “a-” for UniMed and say the outlook for both ratings is stable.

The rating affirmations reflect UniMed’s excellent risk-adjusted capitalisation and solid investment results. The ratings also recognise the company’s initiatives to improve underwriting profitability through revising the pricing structures of its poorer performing products, the ratings agency says.

UniMed’s capitalisation on a risk-adjusted basis, as measured by Best’s Capital Adequacy Ratio (BCAR), demonstrates that the company is strongly capitalised. In addition, the premium leverage ratio is maintained at a conservative level of 0.63 times. Although recent business expansion led to an increase in premium risk, UniMed’s underwriting leverage in relation to its book of business remains prudent. "In AM Best’s opinion, UniMed will maintain its capitalisation at a strong level."

With approximately 88% of invested assets as domestic and currency-hedged fixed-interest investments, UniMed’s investment income is of high quality and deemed to be sustainable. It is expected that the company’s underwriting business will continue to be complemented by a solid stream of investment income.

Offsetting these positive rating factors are the challenging economic conditions and the increasingly competitive environment UniMed faces within the local health insurance industry in New Zealand.

AM Best also takes into account that while management is actively pursuing non-organic growth opportunities, there are potential acquisitions ahead that could put UniMed’s risk-adjusted capitalisation temporarily under pressure.

A significant deterioration in UniMed’s capitalisation could lead to a downgrading of its ratings. However, an improved stability in the company’s underwriting performance could result in an upgrading of its ratings.

« New people, products, commission and more from AsteronNZ should follow Australian health insurance model »

Special Offers

Commenting is closed

 

print

Printable version  

print

Email to a friend
Insurance Briefs

Gut on you Asteron
Asteron Life joins forces with the Gut Foundation as platinum sponsor.

Partners exits Adviser Support Programme
Partners Life has moved its Adviser Support Programme to a third party compliance provider.

Apex Advice buys life business
Auckland-based Apex Advice has acquired a well-established insurance advice business.

Chubb's latest champion
Young maths prodigy takes out actuarial award.

News Bites
Latest Comments
  • [OPINION] Is the risk industry at risk?
    “If you haven't figured out why insurers have by and large decided that the cost of adviser support and service is less important...”
    1 day ago by mentats
  • [OPINION] Is the risk industry at risk?
    “Well said John, an unsurprising read and one that the comments reflect isn’t an unusual experience. The idea that advisers...”
    1 day ago by JPHale
  • [OPINION] Is the risk industry at risk?
    “Some interesting insights into the insurance industry - which (as a non insurance sort) I assumed was an extremely competitive...”
    5 days ago by Pragmatic
  • [OPINION] Is the risk industry at risk?
    “David, I could not agree more and this should be the number 1 issue for any adviser body this year. Current insurer inefficiencies...”
    6 days ago by Backstage
  • [OPINION] Is the risk industry at risk?
    “This issue of poor provider service is more serious than we yet realise. When CoFI hits - shortly - FAPs and FAs will be...”
    6 days ago by dcwhyte
Subscribe Now

Cover Notes - Specific news aimed at risk advisers

Previous News
Most Commented On
About Us  |  Advertise  |  Contact Us  |  Terms & Conditions  |  Privacy Policy  |  RSS Feeds  |  Letters  |  Archive  |  Toolbox  |  Disclaimer
 
Site by Web Developer and eyelovedesign.com
x